同期行经尿道膀胱癌电切术并前列腺增生汽化切割术的临床观察

目的 探讨膀胱癌并前列腺增生患者同期行经尿道膀胱肿瘤电切术加前列腺汽化切割的可行性。方法 回顾性分析54例膀胱癌并前列腺增生患者的手术方法，32例同期行经尿道膀胱肿瘤电切加前列腺气化切割术(A组)，22例单纯行经尿道膀胱肿瘤电切术(B组)。结果 随访6～36个月，A组术后4例复发，无尿道及前列腺窝种植转移；无TUR综合征。B组3例术后复发，再次经尿道手术治疗，另外3例随访期间，因前列腺增生再次行经尿道前列腺电切术。肿瘤复发时间5～19个月，平均13．9个月，均无前列腺窝和原位复发。结论 膀胱肿瘤并前列腺增生患者同期行经尿道手术，不增加合并症，安全、效果可靠、无前列腺窝种植转移。

Transurethral surgery for bladder transitional cell carcinoma with benign prostatic hyperplasia (BPH)

To evaluated the effect of simultaneous transurethral resection of bladder tumor (TURBT) and benign prostatic hyperplasia (TUVP) on recurrences at the bladder neck and prostatic urethra. The clinical data of 54 cases of patients with bladder transitional cell carcinoma and BPH were retrospectively reviewed .Among the patients, 32 had undergone TURBt and TUVP at the same time (group A), and the rest 22 had undergone TURBt alone (group B). The following up period ranged from 6~36 months. The recurrence occurred to 4 cases in group A without implancation at the bladder neck and prostatic urethra and no distance metastase. The recurrence occurred to 3 of 22 in group B. Recurrences appeared within an average of 13.8 months, that was within 8 month, 14 month, 16 month and 19 month in group A and 5 month, 17 month and 18 month in group B respectively. [Conclusions] Our data indicate that simultaneous TURBT and TUVP do not negatively affect tumor implancation at the bladder neck and prostatic urethra, and is a safe and effective alternative treatment.